secwatch.observer — SEC 8-K summary
======================================

Issuer:     ImageneBio, Inc. (IMA)
CIK:        0001835579
Form:       8-K
Filed at:   2023-06-09T23:59:59+00:00
Accession:  0001193125-23-164481
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Ikena Oncology shareholders elect three Class II directors, ratify E&Y as auditor
--------------------------------------------------------------------------------

- David Bonita (16.5M for, 7.6M against, 2.3M broker non-votes) elected to three-year term.
- Jean-François Formela (20.8M for, 3.3M against) and Richard Wooster (20.8M for, 3.3M against) also elected.
- Ernst & Young LLP ratified as independent auditor for FY2023 with 26.4M for, 9k against, 1.3k abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1835579/000119312523164481/0001193125-23-164481-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1835579/000119312523164481/d483896d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-164481

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer